Rate of Recurrence After Discontinuing Anticoagulation Therapy in Patients With COVID-19-Associated Venous Thromboembolism.

Jara-Palomares, LuisBikdeli, BehnoodJiménez, DavidMuriel, AlfonsoMartin Del Pozo, MarDemelo-Rodríguez, PabloMonreal, Manuel2023-05-032023-05-032022http://hdl.handle.net/10668/19507enHumansVenous ThromboembolismCOVID-19AnticoagulantsRecurrenceRisk FactorsRate of Recurrence After Discontinuing Anticoagulation Therapy in Patients With COVID-19-Associated Venous Thromboembolism.research article36342711open access10.1001/jamainternmed.2022.49542168-6114PMC9641587https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2797777/jamainternal_jarapalomares_2022_ld_220038_1670009042.10942.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641587/pdf